SINOVAC BIOTECH LTD (SVA) Net margin 2016–2025
SINOVAC BIOTECH LTD (SVA) net profit margin by fiscal year — reported net income divided by reported revenue.
-51.5%FY2025 · since FY2016: -0.8% → -51.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -51.5% | -62.8 pp |
| FY2024 | 11.3% | +14.1 pp |
| FY2023 | -2.9% | -3.9 pp |
| FY2022 | 1.0% | -41.0 pp |
| FY2021 | 41.9% | +20.3 pp |
| FY2020 | 21.6% | +3.4 pp |
| FY2019 | 18.3% | +8.8 pp |
| FY2018 | 9.5% | -5.3 pp |
| FY2017 | 14.8% | +15.6 pp |
| FY2016 | -0.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice